Department of Medicine

Other Events & Opportunities

Health Equity Advocacy Community Forum: Building Consensus for Action. This session will bring together healthcare professionals, learners, and community members to build consensus around health-related priorities for advocacy. This program will feature collaborative discussion that will have tangible deliverables. Tuesday, November 15, 2022, 4:30 PM – 8:00 PM ET, National Center for Civil and Human Rights. Register here.

Faculty Spotlight:

Raymond Lynch and Neal Dickert named new associate directors of the Health Services Research Center

Transplant surgeon Raymond Lynch, MD, and cardiologist Neal Dickert, MD, PhD, have been named associate directors of the Health Services Research Center (HSRC). They will join founding director Rachel Patzer, PhD, MPH, and the rest of HSRC's leadership team in advancing its mission of increasing healthcare access, quality, value, and outcomes for all patients and populations through scientific inquiry and innovative solutions.

Dr. Lynch joins the HSRC from the Division of Transplantation of the Department of Surgery, where he specializes in liver and kidney transplantation. His health services research interests include resource utilization and outcomes analysis in transplantation, and he is highly dedicated to improving the distribution of grafts to patients with organ failure. Dr. Lynch's work has been used as a basis for new government metrics on deceased donor procurement, and his research and advocacy efforts have been instrumental in bringing focus to barriers in access to transplantation for patients in poor, rural, and medically underserved populations.

Dr. Dickert is a member of the Division of Cardiology of the Department of Medicine. His clinical work focuses on cardiac intensive care, while his research is concentrated on ethics and decision science, particularly the ethical aspects of clinical research. His current research projects are studying the impact of disclosure of out-of-pocket cost information on decision-making, evaluating the impact of recent policy-mandated implementation of shared decision-making tools, and developing and examining innovative approaches to informed consent. As director of the Georgia CTSA Recruitment Center, Dr. Dickert also works to advance integration of clinical research and clinical care across the Emory community.

"We look forward to collaborating with these impressive investigators as we continue the next round of strategic planning for the HSRC," says Dr. Patzer.

Raymond Lynch and Neal Dickert

HSR-Related News

"This study will aim to establish a longitudinal cohort of individuals across the life course — children, pregnant women, adults — who developed diabetes following SARS-CoV-2 infection in order to better understand the pathophysiology and clinical course of post-COVID-19 diabetes," says Jessica Harding, PhD. The study will be funded by the NIDDK.

After analyzing data from three southeastern states, a study led by Rachel Patzer, PhD, MPH, found that following the implementation of the national kidney allocation system (KAS) in 2014, access to early steps in the kidney transplant process increased for some patients.

Anant Madabhushi, PhD, a global leader in developing artificial intelligence to improve outcomes for individuals with cancer and other diseases, will join Emory School of Medicine in July 2022 as part of the university's growing research community focused on advancing AI to serve humanity.

The U.S. Food and Drug Administration has announced that molnupiravir, an oral antiviral drug invented by scientists at Emory University, has received Emergency Use Authorization (EUA) for treatment of COVID-19. Emory has discovered and advanced some of the world’s most important and valuable drugs such as belatacept for kidney transplants, Obizur for hemophilia, and Emtriva for HIV.

Recent Emory HSR Publications